Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01766700 · ClinicalTrials.gov registry record · NA
The Role of No-Calorie Beverages Within a Weight Loss Program
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 308
- Enrollment target
NCT01766700: Completed NA study, sponsored by University of Colorado, Denver.
NCT01766700 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 308 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01766700, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 308 participants
- Enrollment target
Study Summary
The no calorie drink study is looking for over 300 people to participate. The study is evaluating the effect of no calorie beverages on weight loss and weight maintained over time in people who drink diet beverages every day as compared to water only drinkers during the 1 year study period.
Interventions
- BEHAVIORAL 2 no calorie beverages per day
- BEHAVIORAL 2 water beverages per day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT01766700 record still lists
NCT01766700 is an interventional study that assigns participants to a tested intervention. The registered 308 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which 2 no calorie beverages per day is the first listed.
NCT01766700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01766700 about?
NCT01766700 is a clinical study titled "The Role of No-Calorie Beverages Within a Weight Loss Program". The no calorie drink study is looking for over 300 people to participate. The study is evaluating the effect of no calorie beverages on weight loss and weight maintained over time in people who drink diet beverages every day as compared to water only drinkers during the 1 year study period.
What is the current status of trial NCT01766700?
This trial is currently completed. It is a NA study. The enrollment target is 308 participants. The study started on 2012-09. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01766700?
The interventions under investigation include: 2 no calorie beverages per day (BEHAVIORAL), 2 water beverages per day (BEHAVIORAL).
Who is sponsoring clinical trial NCT01766700?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01766700's enrollment target sits among peer trials
308 323rd of 2000 higher than 1,677 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
- NCT06233942 · 308 participants · Phase 1
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia